{"gene":"DZIP3","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2003,"finding":"DZIP3/hRUL138 is a novel RNA-binding RING-H2 E3 ubiquitin ligase; its RNA-binding activity was mapped to a central lysine-rich region, and the RING-H2 domain was shown to be functional and essential for self- and trans-ubiquitylation in vitro and for proteasome-mediated turnover in vivo. GFP-tagged protein localizes to cytoplasmic structures (possibly ER) and is excluded from the nucleus.","method":"In vitro ubiquitylation assay, RING domain mutagenesis, RNA-binding mapping, GFP live imaging/fractionation","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of ubiquitylation with active-site mutagenesis and RNA-binding domain mapping in same study","pmids":["12538761"],"is_preprint":false},{"year":2008,"finding":"DZIP3 (as 2A-HUB/hRUL138) is specifically recruited by the N-CoR/HDAC1/3 complex to gene promoters where it catalyzes monoubiquitination of histone H2A at lysine 119, which represses transcription by blocking FACT recruitment and RNA Pol II release at early elongation; this selectively silences chemokine genes in macrophages.","method":"ChIP, in vitro ubiquitylation assay, Co-IP, knockdown with gene expression readout, RNAP II elongation assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (ChIP, in vitro assay, Co-IP, KD) in a high-citation study","pmids":["18206970"],"is_preprint":false},{"year":2013,"finding":"DZIP3 associates with the lncRNA HOTAIR and with its ubiquitination substrate Ataxin-1; HOTAIR acts as a scaffold to facilitate DZIP3-mediated ubiquitination and proteasomal degradation of Ataxin-1 both in cells and in vitro. HOTAIR upregulation in senescent cells accelerates Ataxin-1 decay via this mechanism.","method":"Co-IP, in vitro ubiquitylation assay, RNA pulldown, knockdown/overexpression with protein stability readout","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted in vitro ubiquitylation plus Co-IP and cellular degradation assays; highly cited","pmids":["24326307"],"is_preprint":false},{"year":2015,"finding":"Dzip3 represses developmental/differentiation-inducible genes in mouse embryonic stem cells through H2AK119 ubiquitylation and by reorganizing 3D chromatin conformation; its target gene set partially overlaps with but is distinct from Ring1B targets.","method":"ChIP-seq, Hi-C/3D chromatin conformation assay, KD with gene expression readout in mES cells","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP-seq, 3D chromatin, KD transcriptomics) in mES cell model","pmids":["26568260"],"is_preprint":false},{"year":2015,"finding":"DZIP3 interacts with CARM1 via its RING domain and acts as a transcriptional coactivator of ERα; it interacts with GRIP1 C-terminal activation domain 2 and enhances GRIP1-CARM1 interaction. DZIP3 E3 ligase activity is dispensable for coactivation, while CARM1 methyltransferase activity partially contributes to synergy. DZIP3 is recruited to ERE-containing promoters of ERα target genes (GREB1, pS2) and its depletion reduces their estradiol-induced expression.","method":"Yeast two-hybrid, Co-IP, ERα reporter assay, siRNA knockdown with qRT-PCR, ChIP","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (Y2H, Co-IP, reporter, ChIP, KD) in single study","pmids":["26505218"],"is_preprint":false},{"year":2016,"finding":"DZIP3 ubiquitinates p53 in vitro, identified through a comprehensive E3 protein array binding and ubiquitination screen.","method":"Wheat cell-free protein array, AlphaScreen binding assay, in vitro ubiquitylation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution but no cellular follow-up for DZIP3-p53 axis specifically","pmids":["27249653"],"is_preprint":false},{"year":2019,"finding":"Knockdown of DZIP3 in hematopoietic cell line models promotes monocytic differentiation, placing DZIP3 as a regulator of myelopoiesis.","method":"siRNA knockdown with differentiation phenotype readout","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 3 — single KD experiment, limited mechanistic follow-up","pmids":["31448224"],"is_preprint":false},{"year":2020,"finding":"DZIP3 stabilizes Cyclin D1 by two distinct mechanisms: (1) its lysine-rich RNA-binding region binds the AU-rich element in the 3' UTR of Cyclin D1 mRNA and stabilizes it; (2) its RING E3-ligase domain promotes K63-linked ubiquitination of Cyclin D1 protein to stabilize it. This activity occurs predominantly in G1 phase, drives cell-cycle progression, and promotes tumor growth and metastasis in mouse and zebrafish cancer models.","method":"RIP (RNA immunoprecipitation), Co-IP, in vitro ubiquitylation assay, domain deletion/mutagenesis, siRNA KD with flow cytometry (G1 arrest), in vivo mouse/zebrafish xenograft","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (RIP, Co-IP, in vitro ubiquitylation, domain mutagenesis, in vivo models) in single study","pmids":["33067265"],"is_preprint":false},{"year":2020,"finding":"RSV G protein upregulates DZIP3 expression, and DZIP3 induces K48-linked ubiquitination and proteasomal degradation of GBP5, thereby counteracting an innate immune restriction factor.","method":"Overexpression/knockdown with protein stability assay, ubiquitination assay (K48 linkage-specific), proteasome inhibitor rescue","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — cellular ubiquitination assay with linkage specificity and rescue experiment, single lab","pmids":["32796072"],"is_preprint":false},{"year":2023,"finding":"Proteomic characterization of the DZIP3 interactome in gastric cancer cells identified an association with the CUL4B complex; knockdown of DZIP3 increased expression of SETD7 and ZBTB4. DZIP3 promotes proliferation and metastasis of gastric cancer cells.","method":"Co-IP/mass spectrometry (PPI proteomics), RNA-seq transcriptomics, siRNA knockdown with proliferation/invasion assays","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 — MS-based interactome plus KD phenotype, but CUL4B interaction not yet mechanistically dissected","pmids":["36841324"],"is_preprint":false},{"year":2026,"finding":"The lncRNA LINCMD1 sequesters DZIP3 in the nucleus by competitive binding, preventing DZIP3 from interacting with cytoplasmic OCTN2 and catalyzing K48-linked ubiquitination and degradation of OCTN2; disrupting this interaction stabilizes OCTN2 and promotes L-carnitine accumulation in MASH-HCC.","method":"Co-IP, subcellular fractionation, ubiquitination assay (K48 linkage), RNA pulldown, antisense oligonucleotide rescue in vivo","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (Co-IP, fractionation, K48 ubiquitination, in vivo rescue) but single lab and very recent","pmids":["41566533"],"is_preprint":false}],"current_model":"DZIP3 is a cytoplasmic/nuclear RNA-binding RING-H2 E3 ubiquitin ligase that uses its lysine-rich region to bind mRNA AU-rich elements and its RING domain to catalyze substrate ubiquitination; it monoubiquitinates histone H2AK119 to repress transcription (in part by reorganizing 3D chromatin), promotes K63-linked ubiquitination of Cyclin D1 to stabilize it and drive G1-phase cell-cycle progression, catalyzes K48-linked ubiquitination and proteasomal degradation of substrates including GBP5 and OCTN2, acts as an ERα transcriptional coactivator in complex with CARM1/GRIP1 (ligase-activity-independent), and its substrate access is regulated by scaffold lncRNAs (HOTAIR, LINCMD1) that bridge or sequester it from specific targets."},"narrative":{"teleology":[{"year":2003,"claim":"The initial characterization established that DZIP3 is a bifunctional protein possessing both RING-H2-dependent E3 ubiquitin ligase activity and RNA-binding capacity through a distinct lysine-rich region, resolving the basic enzymatic identity of the gene product.","evidence":"In vitro ubiquitylation assay with RING domain mutagenesis, RNA-binding domain mapping, and GFP imaging in mammalian cells","pmids":["12538761"],"confidence":"High","gaps":["Physiological substrates and RNA targets were unknown","Whether the RNA-binding and ubiquitin ligase activities are functionally coupled was not addressed","Cytoplasmic localization to possible ER structures was not definitively resolved"]},{"year":2008,"claim":"The discovery that DZIP3 monoubiquitinates H2AK119 as part of the N-CoR/HDAC1/3 repressive complex, blocking FACT recruitment and Pol II elongation at chemokine gene promoters, established its first physiological substrate and a direct chromatin-level mechanism of transcriptional repression.","evidence":"ChIP, Co-IP with N-CoR/HDAC complex, in vitro H2A ubiquitylation, knockdown with gene expression and Pol II elongation readouts in macrophages","pmids":["18206970"],"confidence":"High","gaps":["How DZIP3 is recruited specifically to chemokine gene promoters versus other loci was unclear","Relationship between its RNA-binding function and chromatin role was unexplored","Whether this H2A ubiquitylation operates genome-wide or at select loci was unknown"]},{"year":2013,"claim":"Demonstrating that the lncRNA HOTAIR scaffolds the DZIP3–Ataxin-1 interaction to promote ubiquitination and proteasomal degradation of Ataxin-1 revealed a new regulatory principle: non-coding RNAs can direct DZIP3 substrate specificity.","evidence":"RNA pulldown, Co-IP, in vitro ubiquitylation reconstitution, knockdown/overexpression with protein stability readout in senescent cells","pmids":["24326307"],"confidence":"High","gaps":["Ubiquitin chain linkage type on Ataxin-1 was not specified","Whether other lncRNAs similarly regulate DZIP3 substrate targeting remained open","In vivo relevance of HOTAIR-DZIP3 axis beyond senescence was not tested"]},{"year":2015,"claim":"Genome-wide studies in mouse ES cells extended the H2AK119 ubiquitylation role to developmental gene regulation and showed that DZIP3 reorganizes 3D chromatin conformation at its target loci, distinguishing its target set from the canonical PRC1 component Ring1B.","evidence":"ChIP-seq, Hi-C chromatin conformation analysis, knockdown with transcriptomics in mES cells","pmids":["26568260"],"confidence":"High","gaps":["Mechanism by which DZIP3 alters 3D chromatin architecture was not elucidated","Whether DZIP3 cooperates with or substitutes for PRC1 complexes at shared targets was unresolved"]},{"year":2015,"claim":"Identification of DZIP3 as an ERα coactivator that enhances GRIP1–CARM1 interaction independently of its E3 ligase activity revealed a non-catalytic transcriptional function, expanding its role beyond ubiquitination.","evidence":"Yeast two-hybrid, Co-IP, ERα reporter assay, ChIP at ERE-containing promoters, siRNA knockdown with qRT-PCR in breast cancer cells","pmids":["26505218"],"confidence":"High","gaps":["How ligase-dependent and ligase-independent functions of DZIP3 are coordinated in the same cell was unknown","Whether DZIP3 coactivator function extends to other nuclear receptors was not tested"]},{"year":2020,"claim":"The dual mechanism by which DZIP3 stabilizes Cyclin D1 — binding its mRNA 3′ UTR via the lysine-rich region and catalyzing K63-linked ubiquitination of Cyclin D1 protein via the RING domain — demonstrated that its RNA-binding and ligase activities can converge on the same target to drive G1 cell-cycle progression and tumorigenesis.","evidence":"RIP, Co-IP, in vitro ubiquitylation with K63-linkage specificity, domain mutagenesis, flow cytometry for G1 arrest, mouse and zebrafish xenograft models","pmids":["33067265"],"confidence":"High","gaps":["Whether other DZIP3 targets are similarly regulated at both mRNA and protein levels was unknown","Structural basis for how the lysine-rich region recognizes AU-rich elements was not determined"]},{"year":2020,"claim":"Showing that DZIP3 targets GBP5 for K48-linked ubiquitination and proteasomal degradation upon RSV G protein induction established DZIP3 as an innate immune modulator and demonstrated its capacity for K48-linked chain assembly alongside its K63-linked activity.","evidence":"Overexpression/knockdown with K48-linkage-specific ubiquitination assay, proteasome inhibitor rescue in virus-infected cells","pmids":["32796072"],"confidence":"Medium","gaps":["Whether DZIP3 directly ubiquitinates GBP5 or acts through an intermediate was not fully resolved","Single-lab finding without independent replication","Broader role in antiviral innate immunity beyond RSV was not explored"]},{"year":2023,"claim":"Proteomic identification of the DZIP3 interactome in gastric cancer cells revealed an association with the CUL4B complex and downstream regulation of SETD7 and ZBTB4, suggesting DZIP3 may participate in multi-E3-ligase assemblies.","evidence":"Co-IP/mass spectrometry, RNA-seq, siRNA knockdown with proliferation and invasion assays in gastric cancer cells","pmids":["36841324"],"confidence":"Medium","gaps":["Functional significance of the CUL4B interaction (direct subunit vs. transient association) was not dissected","Whether SETD7 and ZBTB4 are direct ubiquitination substrates was not established","Single-lab study in one cancer type"]},{"year":2026,"claim":"The finding that lncRNA LINCMD1 sequesters DZIP3 in the nucleus to prevent K48-linked ubiquitination and degradation of cytoplasmic OCTN2 established a second lncRNA-based regulatory mechanism and showed that DZIP3 subcellular partitioning controls substrate access.","evidence":"Co-IP, subcellular fractionation, K48-linkage ubiquitination assay, RNA pulldown, antisense oligonucleotide rescue in vivo in MASH-HCC model","pmids":["41566533"],"confidence":"Medium","gaps":["Single-lab finding, awaiting independent validation","Whether nuclear sequestration by LINCMD1 simultaneously affects DZIP3 chromatin functions was not examined","Generalizability of lncRNA-mediated compartmental regulation of DZIP3 beyond LINCMD1 and HOTAIR is unknown"]},{"year":null,"claim":"A unifying model explaining how DZIP3 selects among its diverse ubiquitin chain types (mono, K48, K63) for different substrates, and how its RNA-binding, chromatin, and coactivator functions are spatiotemporally coordinated, remains to be established.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of DZIP3 exists to explain linkage-type specificity or RNA recognition","The E2 ubiquitin-conjugating enzymes that partner with DZIP3 for each chain type are not identified","How DZIP3 is partitioned between cytoplasmic mRNA regulation, nuclear chromatin modification, and coactivator functions in the same cell is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,5,7,8,10]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,7]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,4]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[1,3]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,7,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3,4,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,7,10]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,3]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,7,8,10]}],"complexes":["N-CoR/HDAC1/3 repressive complex"],"partners":["NCOR1","HDAC1","HDAC3","CARM1","GRIP1","CCND1","ATXN1","CUL4B"],"other_free_text":[]},"mechanistic_narrative":"DZIP3 is a multifunctional RNA-binding RING-H2 E3 ubiquitin ligase that couples mRNA regulation with chromatin modification and targeted protein degradation to control gene expression, cell-cycle progression, and innate immunity. Its lysine-rich region binds AU-rich elements in mRNA (e.g., Cyclin D1 3′ UTR), while its RING-H2 domain catalyzes mono- and polyubiquitination with distinct linkage specificities: monoubiquitination of H2AK119 in concert with the N-CoR/HDAC1/3 complex represses transcription by blocking FACT-dependent RNA Pol II elongation and reorganizes 3D chromatin at developmental genes [PMID:18206970, PMID:26568260]; K63-linked ubiquitination stabilizes Cyclin D1 protein to drive G1 progression and tumor growth [PMID:33067265]; and K48-linked ubiquitination targets substrates such as GBP5 and OCTN2 for proteasomal degradation [PMID:32796072, PMID:41566533]. DZIP3 also functions as an ERα transcriptional coactivator in a ligase-activity-independent manner through interaction with CARM1 and GRIP1 [PMID:26505218], and scaffold lncRNAs (HOTAIR, LINCMD1) regulate its substrate access by bridging or sequestering it from specific targets [PMID:24326307, PMID:41566533]."},"prefetch_data":{"uniprot":{"accession":"Q86Y13","full_name":"E3 ubiquitin-protein ligase DZIP3","aliases":["DAZ-interacting protein 3","RING-type E3 ubiquitin transferase DZIP3","RNA-binding ubiquitin ligase of 138 kDa","hRUL138"],"length_aa":1208,"mass_kda":138.6,"function":"E3 Ubiquitin ligase proteins mediate ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Able to specifically bind RNA","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q86Y13/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DZIP3","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DZIP3","total_profiled":1310},"omim":[{"mim_id":"608672","title":"DAZ-INTERACTING ZINC FINGER PROTEIN 3; DZIP3","url":"https://www.omim.org/entry/608672"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DZIP3"},"hgnc":{"alias_symbol":["hRUL138","PPP1R66"],"prev_symbol":[]},"alphafold":{"accession":"Q86Y13","domains":[{"cath_id":"1.25.40,1.10.3450","chopping":"48-220_228-247","consensus_level":"medium","plddt":71.7149,"start":48,"end":247},{"cath_id":"-","chopping":"250-341","consensus_level":"medium","plddt":74.0146,"start":250,"end":341},{"cath_id":"-","chopping":"390-586","consensus_level":"high","plddt":73.9441,"start":390,"end":586},{"cath_id":"-","chopping":"787-967","consensus_level":"high","plddt":86.1757,"start":787,"end":967},{"cath_id":"-","chopping":"1037-1079","consensus_level":"high","plddt":79.5116,"start":1037,"end":1079},{"cath_id":"3.30.40.10","chopping":"1148-1198","consensus_level":"medium","plddt":80.3496,"start":1148,"end":1198}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86Y13","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86Y13-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86Y13-F1-predicted_aligned_error_v6.png","plddt_mean":62.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DZIP3","jax_strain_url":"https://www.jax.org/strain/search?query=DZIP3"},"sequence":{"accession":"Q86Y13","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86Y13.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86Y13/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86Y13"}},"corpus_meta":[{"pmid":"24326307","id":"PMC_24326307","title":"Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24326307","citation_count":370,"is_preprint":false},{"pmid":"18206970","id":"PMC_18206970","title":"Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18206970","citation_count":307,"is_preprint":false},{"pmid":"25926359","id":"PMC_25926359","title":"ATRX contributes to epigenetic asymmetry and silencing of major satellite transcripts in the maternal genome of the mouse embryo.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25926359","citation_count":49,"is_preprint":false},{"pmid":"32796072","id":"PMC_32796072","title":"GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.","date":"2020","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/32796072","citation_count":43,"is_preprint":false},{"pmid":"27249653","id":"PMC_27249653","title":"Establishment of a Wheat Cell-Free Synthesized Protein Array Containing 250 Human and Mouse E3 Ubiquitin Ligases to Identify Novel Interaction between E3 Ligases and Substrate Proteins.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27249653","citation_count":39,"is_preprint":false},{"pmid":"33067265","id":"PMC_33067265","title":"RNA-Binding RING E3-Ligase DZIP3/hRUL138 Stabilizes Cyclin D1 to Drive Cell-Cycle and Cancer Progression.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33067265","citation_count":24,"is_preprint":false},{"pmid":"36351462","id":"PMC_36351462","title":"A high-quality, haplotype-phased genome reconstruction reveals unexpected haplotype diversity in a pearl oyster.","date":"2022","source":"DNA research : an international journal for rapid publication of reports on genes and genomes","url":"https://pubmed.ncbi.nlm.nih.gov/36351462","citation_count":23,"is_preprint":false},{"pmid":"12538761","id":"PMC_12538761","title":"hRUL138, a novel human RNA-binding RING-H2 ubiquitin-protein ligase.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12538761","citation_count":21,"is_preprint":false},{"pmid":"31099175","id":"PMC_31099175","title":"Genome-wide association study identifies loci associated with liability to alcohol and drug dependence that is associated with variability in reward-related ventral striatum activity in African- and European-Americans.","date":"2019","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/31099175","citation_count":19,"is_preprint":false},{"pmid":"31448224","id":"PMC_31448224","title":"Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.","date":"2019","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31448224","citation_count":17,"is_preprint":false},{"pmid":"26568260","id":"PMC_26568260","title":"Dzip3 regulates developmental genes in mouse embryonic stem cells by reorganizing 3D chromatin conformation.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26568260","citation_count":14,"is_preprint":false},{"pmid":"26505218","id":"PMC_26505218","title":"Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α.","date":"2015","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/26505218","citation_count":11,"is_preprint":false},{"pmid":"33330022","id":"PMC_33330022","title":"Blood Cell DNA Methylation of Aging-Related Ubiquitination Gene DZIP3 Can Predict the Onset of Early Stage Colorectal Cancer.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33330022","citation_count":9,"is_preprint":false},{"pmid":"35993275","id":"PMC_35993275","title":"The A to I editing landscape in melanoma and its relation to clinical outcome.","date":"2022","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/35993275","citation_count":9,"is_preprint":false},{"pmid":"33229627","id":"PMC_33229627","title":"DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33229627","citation_count":5,"is_preprint":false},{"pmid":"36841324","id":"PMC_36841324","title":"Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells.","date":"2023","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36841324","citation_count":1,"is_preprint":false},{"pmid":"29812999","id":"PMC_29812999","title":"Generation of Rat Monoclonal Antibodies Specific for DZIP3.","date":"2018","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/29812999","citation_count":1,"is_preprint":false},{"pmid":"41566533","id":"PMC_41566533","title":"OCTN2 Activates a Non-Canonical Carnitine Metabolic Pathway to Promote MASH-HCC Progression and Immunotherapy Resistance.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41566533","citation_count":0,"is_preprint":false},{"pmid":"40626177","id":"PMC_40626177","title":"CYLD as a key regulator of myocardial infarction-to-heart failure transition revealed by multi-omics integration.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40626177","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11260,"output_tokens":2751,"usd":0.037523},"stage2":{"model":"claude-opus-4-6","input_tokens":6099,"output_tokens":3200,"usd":0.165742},"total_usd":0.203265,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"DZIP3/hRUL138 is a novel RNA-binding RING-H2 E3 ubiquitin ligase; its RNA-binding activity was mapped to a central lysine-rich region, and the RING-H2 domain was shown to be functional and essential for self- and trans-ubiquitylation in vitro and for proteasome-mediated turnover in vivo. GFP-tagged protein localizes to cytoplasmic structures (possibly ER) and is excluded from the nucleus.\",\n      \"method\": \"In vitro ubiquitylation assay, RING domain mutagenesis, RNA-binding mapping, GFP live imaging/fractionation\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of ubiquitylation with active-site mutagenesis and RNA-binding domain mapping in same study\",\n      \"pmids\": [\"12538761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DZIP3 (as 2A-HUB/hRUL138) is specifically recruited by the N-CoR/HDAC1/3 complex to gene promoters where it catalyzes monoubiquitination of histone H2A at lysine 119, which represses transcription by blocking FACT recruitment and RNA Pol II release at early elongation; this selectively silences chemokine genes in macrophages.\",\n      \"method\": \"ChIP, in vitro ubiquitylation assay, Co-IP, knockdown with gene expression readout, RNAP II elongation assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (ChIP, in vitro assay, Co-IP, KD) in a high-citation study\",\n      \"pmids\": [\"18206970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DZIP3 associates with the lncRNA HOTAIR and with its ubiquitination substrate Ataxin-1; HOTAIR acts as a scaffold to facilitate DZIP3-mediated ubiquitination and proteasomal degradation of Ataxin-1 both in cells and in vitro. HOTAIR upregulation in senescent cells accelerates Ataxin-1 decay via this mechanism.\",\n      \"method\": \"Co-IP, in vitro ubiquitylation assay, RNA pulldown, knockdown/overexpression with protein stability readout\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted in vitro ubiquitylation plus Co-IP and cellular degradation assays; highly cited\",\n      \"pmids\": [\"24326307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dzip3 represses developmental/differentiation-inducible genes in mouse embryonic stem cells through H2AK119 ubiquitylation and by reorganizing 3D chromatin conformation; its target gene set partially overlaps with but is distinct from Ring1B targets.\",\n      \"method\": \"ChIP-seq, Hi-C/3D chromatin conformation assay, KD with gene expression readout in mES cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP-seq, 3D chromatin, KD transcriptomics) in mES cell model\",\n      \"pmids\": [\"26568260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DZIP3 interacts with CARM1 via its RING domain and acts as a transcriptional coactivator of ERα; it interacts with GRIP1 C-terminal activation domain 2 and enhances GRIP1-CARM1 interaction. DZIP3 E3 ligase activity is dispensable for coactivation, while CARM1 methyltransferase activity partially contributes to synergy. DZIP3 is recruited to ERE-containing promoters of ERα target genes (GREB1, pS2) and its depletion reduces their estradiol-induced expression.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, ERα reporter assay, siRNA knockdown with qRT-PCR, ChIP\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Y2H, Co-IP, reporter, ChIP, KD) in single study\",\n      \"pmids\": [\"26505218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DZIP3 ubiquitinates p53 in vitro, identified through a comprehensive E3 protein array binding and ubiquitination screen.\",\n      \"method\": \"Wheat cell-free protein array, AlphaScreen binding assay, in vitro ubiquitylation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution but no cellular follow-up for DZIP3-p53 axis specifically\",\n      \"pmids\": [\"27249653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Knockdown of DZIP3 in hematopoietic cell line models promotes monocytic differentiation, placing DZIP3 as a regulator of myelopoiesis.\",\n      \"method\": \"siRNA knockdown with differentiation phenotype readout\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single KD experiment, limited mechanistic follow-up\",\n      \"pmids\": [\"31448224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DZIP3 stabilizes Cyclin D1 by two distinct mechanisms: (1) its lysine-rich RNA-binding region binds the AU-rich element in the 3' UTR of Cyclin D1 mRNA and stabilizes it; (2) its RING E3-ligase domain promotes K63-linked ubiquitination of Cyclin D1 protein to stabilize it. This activity occurs predominantly in G1 phase, drives cell-cycle progression, and promotes tumor growth and metastasis in mouse and zebrafish cancer models.\",\n      \"method\": \"RIP (RNA immunoprecipitation), Co-IP, in vitro ubiquitylation assay, domain deletion/mutagenesis, siRNA KD with flow cytometry (G1 arrest), in vivo mouse/zebrafish xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (RIP, Co-IP, in vitro ubiquitylation, domain mutagenesis, in vivo models) in single study\",\n      \"pmids\": [\"33067265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RSV G protein upregulates DZIP3 expression, and DZIP3 induces K48-linked ubiquitination and proteasomal degradation of GBP5, thereby counteracting an innate immune restriction factor.\",\n      \"method\": \"Overexpression/knockdown with protein stability assay, ubiquitination assay (K48 linkage-specific), proteasome inhibitor rescue\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cellular ubiquitination assay with linkage specificity and rescue experiment, single lab\",\n      \"pmids\": [\"32796072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Proteomic characterization of the DZIP3 interactome in gastric cancer cells identified an association with the CUL4B complex; knockdown of DZIP3 increased expression of SETD7 and ZBTB4. DZIP3 promotes proliferation and metastasis of gastric cancer cells.\",\n      \"method\": \"Co-IP/mass spectrometry (PPI proteomics), RNA-seq transcriptomics, siRNA knockdown with proliferation/invasion assays\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — MS-based interactome plus KD phenotype, but CUL4B interaction not yet mechanistically dissected\",\n      \"pmids\": [\"36841324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"The lncRNA LINCMD1 sequesters DZIP3 in the nucleus by competitive binding, preventing DZIP3 from interacting with cytoplasmic OCTN2 and catalyzing K48-linked ubiquitination and degradation of OCTN2; disrupting this interaction stabilizes OCTN2 and promotes L-carnitine accumulation in MASH-HCC.\",\n      \"method\": \"Co-IP, subcellular fractionation, ubiquitination assay (K48 linkage), RNA pulldown, antisense oligonucleotide rescue in vivo\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (Co-IP, fractionation, K48 ubiquitination, in vivo rescue) but single lab and very recent\",\n      \"pmids\": [\"41566533\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DZIP3 is a cytoplasmic/nuclear RNA-binding RING-H2 E3 ubiquitin ligase that uses its lysine-rich region to bind mRNA AU-rich elements and its RING domain to catalyze substrate ubiquitination; it monoubiquitinates histone H2AK119 to repress transcription (in part by reorganizing 3D chromatin), promotes K63-linked ubiquitination of Cyclin D1 to stabilize it and drive G1-phase cell-cycle progression, catalyzes K48-linked ubiquitination and proteasomal degradation of substrates including GBP5 and OCTN2, acts as an ERα transcriptional coactivator in complex with CARM1/GRIP1 (ligase-activity-independent), and its substrate access is regulated by scaffold lncRNAs (HOTAIR, LINCMD1) that bridge or sequester it from specific targets.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DZIP3 is a multifunctional RNA-binding RING-H2 E3 ubiquitin ligase that couples mRNA regulation with chromatin modification and targeted protein degradation to control gene expression, cell-cycle progression, and innate immunity. Its lysine-rich region binds AU-rich elements in mRNA (e.g., Cyclin D1 3′ UTR), while its RING-H2 domain catalyzes mono- and polyubiquitination with distinct linkage specificities: monoubiquitination of H2AK119 in concert with the N-CoR/HDAC1/3 complex represses transcription by blocking FACT-dependent RNA Pol II elongation and reorganizes 3D chromatin at developmental genes [PMID:18206970, PMID:26568260]; K63-linked ubiquitination stabilizes Cyclin D1 protein to drive G1 progression and tumor growth [PMID:33067265]; and K48-linked ubiquitination targets substrates such as GBP5 and OCTN2 for proteasomal degradation [PMID:32796072, PMID:41566533]. DZIP3 also functions as an ERα transcriptional coactivator in a ligase-activity-independent manner through interaction with CARM1 and GRIP1 [PMID:26505218], and scaffold lncRNAs (HOTAIR, LINCMD1) regulate its substrate access by bridging or sequestering it from specific targets [PMID:24326307, PMID:41566533].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"The initial characterization established that DZIP3 is a bifunctional protein possessing both RING-H2-dependent E3 ubiquitin ligase activity and RNA-binding capacity through a distinct lysine-rich region, resolving the basic enzymatic identity of the gene product.\",\n      \"evidence\": \"In vitro ubiquitylation assay with RING domain mutagenesis, RNA-binding domain mapping, and GFP imaging in mammalian cells\",\n      \"pmids\": [\"12538761\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological substrates and RNA targets were unknown\",\n        \"Whether the RNA-binding and ubiquitin ligase activities are functionally coupled was not addressed\",\n        \"Cytoplasmic localization to possible ER structures was not definitively resolved\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The discovery that DZIP3 monoubiquitinates H2AK119 as part of the N-CoR/HDAC1/3 repressive complex, blocking FACT recruitment and Pol II elongation at chemokine gene promoters, established its first physiological substrate and a direct chromatin-level mechanism of transcriptional repression.\",\n      \"evidence\": \"ChIP, Co-IP with N-CoR/HDAC complex, in vitro H2A ubiquitylation, knockdown with gene expression and Pol II elongation readouts in macrophages\",\n      \"pmids\": [\"18206970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How DZIP3 is recruited specifically to chemokine gene promoters versus other loci was unclear\",\n        \"Relationship between its RNA-binding function and chromatin role was unexplored\",\n        \"Whether this H2A ubiquitylation operates genome-wide or at select loci was unknown\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that the lncRNA HOTAIR scaffolds the DZIP3–Ataxin-1 interaction to promote ubiquitination and proteasomal degradation of Ataxin-1 revealed a new regulatory principle: non-coding RNAs can direct DZIP3 substrate specificity.\",\n      \"evidence\": \"RNA pulldown, Co-IP, in vitro ubiquitylation reconstitution, knockdown/overexpression with protein stability readout in senescent cells\",\n      \"pmids\": [\"24326307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Ubiquitin chain linkage type on Ataxin-1 was not specified\",\n        \"Whether other lncRNAs similarly regulate DZIP3 substrate targeting remained open\",\n        \"In vivo relevance of HOTAIR-DZIP3 axis beyond senescence was not tested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genome-wide studies in mouse ES cells extended the H2AK119 ubiquitylation role to developmental gene regulation and showed that DZIP3 reorganizes 3D chromatin conformation at its target loci, distinguishing its target set from the canonical PRC1 component Ring1B.\",\n      \"evidence\": \"ChIP-seq, Hi-C chromatin conformation analysis, knockdown with transcriptomics in mES cells\",\n      \"pmids\": [\"26568260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which DZIP3 alters 3D chromatin architecture was not elucidated\",\n        \"Whether DZIP3 cooperates with or substitutes for PRC1 complexes at shared targets was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of DZIP3 as an ERα coactivator that enhances GRIP1–CARM1 interaction independently of its E3 ligase activity revealed a non-catalytic transcriptional function, expanding its role beyond ubiquitination.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, ERα reporter assay, ChIP at ERE-containing promoters, siRNA knockdown with qRT-PCR in breast cancer cells\",\n      \"pmids\": [\"26505218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How ligase-dependent and ligase-independent functions of DZIP3 are coordinated in the same cell was unknown\",\n        \"Whether DZIP3 coactivator function extends to other nuclear receptors was not tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The dual mechanism by which DZIP3 stabilizes Cyclin D1 — binding its mRNA 3′ UTR via the lysine-rich region and catalyzing K63-linked ubiquitination of Cyclin D1 protein via the RING domain — demonstrated that its RNA-binding and ligase activities can converge on the same target to drive G1 cell-cycle progression and tumorigenesis.\",\n      \"evidence\": \"RIP, Co-IP, in vitro ubiquitylation with K63-linkage specificity, domain mutagenesis, flow cytometry for G1 arrest, mouse and zebrafish xenograft models\",\n      \"pmids\": [\"33067265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether other DZIP3 targets are similarly regulated at both mRNA and protein levels was unknown\",\n        \"Structural basis for how the lysine-rich region recognizes AU-rich elements was not determined\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing that DZIP3 targets GBP5 for K48-linked ubiquitination and proteasomal degradation upon RSV G protein induction established DZIP3 as an innate immune modulator and demonstrated its capacity for K48-linked chain assembly alongside its K63-linked activity.\",\n      \"evidence\": \"Overexpression/knockdown with K48-linkage-specific ubiquitination assay, proteasome inhibitor rescue in virus-infected cells\",\n      \"pmids\": [\"32796072\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether DZIP3 directly ubiquitinates GBP5 or acts through an intermediate was not fully resolved\",\n        \"Single-lab finding without independent replication\",\n        \"Broader role in antiviral innate immunity beyond RSV was not explored\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Proteomic identification of the DZIP3 interactome in gastric cancer cells revealed an association with the CUL4B complex and downstream regulation of SETD7 and ZBTB4, suggesting DZIP3 may participate in multi-E3-ligase assemblies.\",\n      \"evidence\": \"Co-IP/mass spectrometry, RNA-seq, siRNA knockdown with proliferation and invasion assays in gastric cancer cells\",\n      \"pmids\": [\"36841324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional significance of the CUL4B interaction (direct subunit vs. transient association) was not dissected\",\n        \"Whether SETD7 and ZBTB4 are direct ubiquitination substrates was not established\",\n        \"Single-lab study in one cancer type\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"The finding that lncRNA LINCMD1 sequesters DZIP3 in the nucleus to prevent K48-linked ubiquitination and degradation of cytoplasmic OCTN2 established a second lncRNA-based regulatory mechanism and showed that DZIP3 subcellular partitioning controls substrate access.\",\n      \"evidence\": \"Co-IP, subcellular fractionation, K48-linkage ubiquitination assay, RNA pulldown, antisense oligonucleotide rescue in vivo in MASH-HCC model\",\n      \"pmids\": [\"41566533\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab finding, awaiting independent validation\",\n        \"Whether nuclear sequestration by LINCMD1 simultaneously affects DZIP3 chromatin functions was not examined\",\n        \"Generalizability of lncRNA-mediated compartmental regulation of DZIP3 beyond LINCMD1 and HOTAIR is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unifying model explaining how DZIP3 selects among its diverse ubiquitin chain types (mono, K48, K63) for different substrates, and how its RNA-binding, chromatin, and coactivator functions are spatiotemporally coordinated, remains to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of DZIP3 exists to explain linkage-type specificity or RNA recognition\",\n        \"The E2 ubiquitin-conjugating enzymes that partner with DZIP3 for each chain type are not identified\",\n        \"How DZIP3 is partitioned between cytoplasmic mRNA regulation, nuclear chromatin modification, and coactivator functions in the same cell is unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 5, 7, 8, 10]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 4, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 7, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 7, 8, 10]}\n    ],\n    \"complexes\": [\n      \"N-CoR/HDAC1/3 repressive complex\"\n    ],\n    \"partners\": [\n      \"NCOR1\",\n      \"HDAC1\",\n      \"HDAC3\",\n      \"CARM1\",\n      \"GRIP1\",\n      \"CCND1\",\n      \"ATXN1\",\n      \"CUL4B\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}